Key result
DDD transvenous pacing boosts Micra AV synchrony to ~82% in a case report.
Why the study?
Leadless pacemakers were developed to provide cardiac pacing without transvenous leads, preventing complications related to vein access and long-term lead presence.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Pacemakers were developed as the only practical solution to treat bradyarrhythmias. Initially pacemakers had wires connected to the external machine; a few years later an internal pacemaker with pulse generator and transvenous leads was developed. Later, leadless pacemakers were developed to provide cardiac pacing without the need of transvenous leads, thus preventing complications of subclavian and axillary vein access and those related to the long-term presence of leads, such as tricuspid regurgitation.
No takes yet. Share an insight, caveat, or question.
Teodorovich et al. (2021) conducted a case report in Sinus node dysfunction and intermittent atrioventricular block (n=1). Micra AV leadless pacemaker combined with existing transvenous pacemaker programmed to DDD mode vs. Existing transvenous pacemaker programmed to AAI mode was evaluated on Atrioventricular (AV) synchrony. Programming an existing transvenous pacemaker to DDD mode improved atrioventricular synchrony with a newly implanted Micra AV leadless pacemaker from 15.9% to 82.4%.
Synapse has enriched 10 related papers. Consider them for comparative context: